Danyi WenFounder, President & CEO at LIDE BiotechSpeaker
Profile
Dr. Wen’s research foundation was 12 years at Millennium Pharmaceutical and Biogen-Idec in Boston, MA. In 2007, inspired by the innovation originating from home, she returned to China as VP of Biology at Shanghai ChemPartner. She founded Shanghai LIDE Biotech in 2011 to drive research and development in personalized precision medicine. She holds a B.S. from the Fourth Military Medical University, an M.S. (M.D. equivalent) from Peking Union Medical University / Chinese Academy of Medical Sciences, and an MBA from Suffolk University. She did her post-doc at Harvard Medical School, Brigham & Women’s Hospital, followed by a two-year junior faculty position (Instructor in Medicine) at Harvard Medical School.
Agenda Sessions
From Data to Deal: Making APAC Pre-Clinical & Clinical Data Globally Actionable
, 13:30View Session
